Skip to main content

Table 1 Summary of the samples available concerning the 79 patients included in the study

From: NRAS Q61R, BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Both primary tumor and metastasis 33
More than one metastasis without primary melanoma 5
Only one metastasis without primary melanoma 26
Only primary melanoma 15